Literature DB >> 32888385

Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa.

Arun C Inamadar1.   

Abstract

A 6-year-old child with recessive dystrophic epidermolysis bullosa, confirmed by history, clinical exam, and antigen mapping, was treated with losartan with reduction in the blistering and better quality of life.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  epidermolysis bullosa; losartan; recessive dystrophic epidermolysis bullosa

Mesh:

Substances:

Year:  2020        PMID: 32888385     DOI: 10.1111/dth.14279

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  1 in total

Review 1.  Case Report: Recessive Dystrophic Epidermolysis Bullosa With Severe Esophageal Stenosis: A Case Report and Literature Review.

Authors:  Zhen Xu; Tianqiao Huang; Min Pan; Yichuan Huang; Yan Jiang
Journal:  Br J Biomed Sci       Date:  2022-03-23       Impact factor: 2.432

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.